Andrea Dillon

APrf Andrea Dillon

Associate Professor

School of Medicine

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

I completed my PhD in cancer research at the University Adelaide in 2004, where I identified a new receptor target for the novel tyrosine kinase inhibitor, imatinib. These key findings were patented by Novartis Pharmaceuticals. I transitioned into Medical Education at the University of Adelaide in 2011 as a case based learning tutor, before becoming an academic in the Adelaide Medical School in 2016.   I am Program Director for the Bachelor of Medical Studies, which transitions into the Doctor of Medicine (MD) program, and am Course Coordinator for Medical Studies 1 (year 1).   I have played a significant role in curriculum development for the new Bachelor of Medical Studies/MD program, with a significant interest in feedback processes and active learning opportunities. 

Date Position Institution name
2022 - ongoing Course Coordinator, Medical Studies 1 University of Adelaide
2019 - ongoing Program Director , Bachelor of Medical Studies University of Adelaide
2019 - 2024 Bachelor of Medical Studies/MD Curriculum Development University of Adelaide
2016 - 2021 Course Coordinator Scientific Basis of Medicine (Y1) University of Adelaide
2011 - 2020 Case Based Learning Tutor University of Adelaide

Date Type Title Institution Name Country Amount
2021 Award Adelaide Medical Student Society Award: Richard Pellew Prize, in recognition of outstanding teaching and service University of Adelaide Australia -
2003 Scholarship Lions Club Medical Research Foundation Scholarship Lions Club of South Australia Australia -

Date Institution name Country Title
2001 - 2004 University of Adelaide Australia PhD
1998 - 1998 University of Tasmania Australia First Class Honours
1995 - 1997 University of Tasmania Australia Bachelor of Science

Year Citation
2025 Arnold, M., Dillon, A., Mingorance, C., & King, S. (2025). The Learning-Teaching Nexus: Medical Students' Motivations to Engage in Peer-Assisted Learning.. Clin Teach, 22(4), e70108.
DOI Scopus2 WoS2 Europe PMC2
2010 Vandyke, K., Dewar, A., Diamond, P., Fitter, S., Schultz, C., Sims, N., & Zannettino, A. (2010). The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo. Journal of Bone and Mineral Research, 25(8), 1759-1770.
DOI Scopus88 WoS82 Europe PMC77
2010 Vandyke, K., Fitter, S., Dewar, A., Hughes, T., & Zannettino, A. (2010). Dysregulation of bone remodeling by imatinib mesylate. Blood, 115(4), 766-774.
DOI Scopus130 WoS116 Europe PMC99
2009 Vandyke, K., Dewar, A., Menicanin, D., To, L., Hughes, T., Zannettino, A., & Fitter, S. (2009). Imatinib mesylate causes growth plate closure in vivo. Leukemia, 23(11), 2155-2159.
DOI Scopus37 WoS35 Europe PMC36
2009 Vandyke, K., Dewar, A., Farrugia, A., Fitter, S., To, B., Hughes, T., & Zannettino, A. (2009). Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis. Leukemia, 23(5), 994-997.
DOI Scopus49 WoS48 Europe PMC43
2008 Fitter, S., Dewar, A., Kostakis, P., To, L., Hughes, T., Roberts, M., . . . Zannettino, A. (2008). Long-term imatinib therapy promotes bone formation in CML patients. Blood, 111(5), 2538-2547.
DOI Scopus147 WoS135 Europe PMC124
2006 Martin, S., Dewar, A., Farrugia, A., Horvath, N., Gronthos, S., To, L., & Zannettino, A. (2006). Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1α in patients with multiple myeloma. Clinical Cancer Research, 12(23), 6973-6977.
DOI Scopus33 WoS30 Europe PMC25
2006 Dewar, A., Farrugia, A., Condina, M., To, L., Hughes, T., Vernon-Roberts, B., & Zannettino, A. (2006). Imatinib as a potential antiresorptive therapy for bone disease. Blood, 107(11), 4334-4337.
DOI Scopus70 WoS67 Europe PMC62
2005 Dewar, A., Cambareri, A., Zannettino, A., Boog, B., Doherty, K., Hughes, T., & Lyons, A. (2005). Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood, 105(8), 3127-3132.
DOI Scopus278 WoS258 Europe PMC216
2005 Dewar, A., Zannettino, A., Hughes, T., & Lyons, A. (2005). Inhibition of c-fms by imatinib - Expanding the spectrum of treatment. Cell Cycle, 4(7), 851-853.
DOI Scopus46 WoS45 Europe PMC39
2005 Dewar, A., Doherty, K., Hughes, T., & Lyons, A. (2005). Imatinib inhibits the functional capacity of cultured human monocytes. Immunology and Cell Biology, 83(1), 48-56.
DOI Scopus38 WoS38 Europe PMC30
2003 Dewar, A., Domaschenz, R., Doherty, K., Hughes, T., & Lyons, A. (2003). Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors. Leukemia, 17(9), 1713-1721.
DOI Scopus54 WoS50 Europe PMC42
2001 Dewar, A., Doherty, K., Woods, G., Lyons, A., & Muller, K. (2001). Acquisition of immune function during the development of the Langerhans cell network in neonatal mice. Immunology, 103(1), 61-69.
DOI Scopus36 WoS36 Europe PMC29
2001 Woods, G. M., Chen, Y. P., Dewar, A. L., Doherty, K. V., Toh, B. H., & Muller, H. K. (2001). Prevention of autoimmunity by induction of cutaneous tolerance. Cellular Immunology, 207(1), 1-5.
DOI Scopus5 Europe PMC5

Year Citation
2025 Dillon, A., Canny, B., Sage Jacobson, S., & Boylan, A. (2025). Assessment of professional behaviour as a mechanism to encourage undergraduate medical students to prioritise wellbeing. In ANZAHPE 2025. Perth, Australia.
2025 Anakin, M., King, S., & Dillon, A. (2025). Developing Interdisciplinary Research Teams: Collaboration or Chaos?. In ANZAHPE 2025. Perth, Australia.
2024 Dillon, A., Fawcett, L., Walters, K., Mingorance, C., Arnold, M., Larkin, M., . . . Thomas, K. (2024). A multi-faceted approach to support Indigenous students: Yarning Circles, cultural retreat & near-peer tutoring. In ANZAHPE 2024. Adelaide, Australia.
2023 Dillon, A., Arnold, M., Mingorance, C., Holmes-Liew, C. L., & Canny, B. (2023). Reflecting on the success of introducing early clinical interactions (ECIs) into a new undergraduate medical program. In ANZAHPE 2023. Gold Coast, Australia.
2023 Arnold, M., Dillon, A., Mingorance, C., Beckett, E., & Canny, B. (2023). Scenario-Based Learning (SBL) - evolving inquiry-based learning strategies for a new MD program. In .. Gold Coast.

2023: UCAT ANZ Research Grant: Determining the relationship between selection tools and early academic performance for international medical/dental students: $72,000

2022: Learning and Teaching Advancement Grant: Team Small Project Grant: Digital Solution to EnhanceIndividualised Feedback to Students for Assessments Conducted in MyUni Quizzes: $5,000

I enjoy teaching in scenario based learning (flipped classroom) which supports students to develop deeper learning through application of knowledge to clinically relevant scenarios.  I also lead delivery of  Early Clinical Interactions, where patients speak to students about their experience of living with disease, and the multi-disciplinary team (MDT) highlight the critical role they play in the patient journey. As Program Director, I also provide significant support to students across the Bachelor of Medical Studies program. I am an active member of the Adelaide Education Academy to further develop and support my teaching practices, and to support other academics across the University. 

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor Career Pathways and Professional Identity Formation in Medical Educators Doctor of Philosophy Doctorate Part Time Mr Matthew Jon Arnold
2025 Principal Supervisor Career Pathways and Professional Identity Formation in Medical Educators - Doctorate Part Time Mr Matthew Jon Arnold

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2007 - 2010 Co-Supervisor Effect of tyrosine kinase inhibition on bone remodelling Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, Australia - Postdoctorate Full Time Kate Vandyke
2005 - 2005 Co-Supervisor Imatinib as a potential antiresorptive therapy for bone disease Hanson Institute, Institute of Medical and Veterinary Science - Honours Full Time Mark Condina

Date Role Committee Institution Country
2023 - ongoing Member Adelaide Medical School Titleholders Committee University of Adelaide Australia
2022 - ongoing Member BMedSt/MD Curriculum Committee University of Adelaide Australia
2021 - ongoing Member BMedSt/MD Governance Committee University of Adelaide Australia
2020 - ongoing Member Adelaide Medical School Executive Committee University of Adelaide Australia
2020 - ongoing Member Medical Programs Assessment Committee (MPAC) University of Adelaide Australia
2020 - ongoing Chair Year 1-3 BMedSt Sub-Committee University of Adelaide Australia
2020 - ongoing Chair Bachelor of Medical Studies Assessment Review Committee University of Adelaide Australia
2020 - ongoing Co-Chair Adelaide Medical School Learning & Teaching Committee University of Adelaide Australia
2020 - ongoing Member Faculty Learning & Teaching Committee, Faculty of Health & Medical Sciences University of Adelaide Australia
2019 - ongoing Member Medical Programs Oversite & Operations Committee University of Adelaide Australia

Date Role Membership Country
2023 - ongoing Member Adelaide College of Reviewers Australia
2023 - ongoing Member Ally Working Group Australia
2020 - ongoing Member Australian and New Zealand Association for Health Professional Educators Australia
2019 - ongoing Member MBBS Admissions Working Group Australia
2019 - ongoing Member Adelaide Education Academy Australia

Connect With Me

External Profiles

Other Links